Down-regulated SMARCA1 might contribute to DNA injury, growth restriction and tumor cell apoptosis in breast cancer [59] were previously reported, without providing prognosis analysis and other bioinformation. This evidence concerns the gene SMARCA1 and breast carcinoma.